{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Biotine : Questions médicales les plus fréquentes",
"headline": "Biotine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Biotine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-15",
"dateModified": "2025-04-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Biotine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Coenzymes",
"url": "https://questionsmedicales.fr/mesh/D003067",
"about": {
"@type": "MedicalCondition",
"name": "Coenzymes",
"code": {
"@type": "MedicalCode",
"code": "D003067",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.211"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Biotine",
"alternateName": "Biotin",
"code": {
"@type": "MedicalCode",
"code": "D001710",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Vesa P Hytönen",
"url": "https://questionsmedicales.fr/author/Vesa%20P%20Hyt%C3%B6nen",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Medicine and Health Technology and BioMediTech, Tampere University, Tampere, Finland; Fimlab Laboratories, Tampere, Finland. Electronic address: vesa.hytonen@tuni.fi."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Ying Wang",
"url": "https://questionsmedicales.fr/author/Ying%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China."
}
},
{
"@type": "Person",
"name": "John H T Luong",
"url": "https://questionsmedicales.fr/author/John%20H%20T%20Luong",
"affiliation": {
"@type": "Organization",
"name": "School of Chemistry and Analytical & Biological Chemistry Research Facility, University College Cork, Cork, Ireland."
}
},
{
"@type": "Person",
"name": "Amitava Dasgupta",
"url": "https://questionsmedicales.fr/author/Amitava%20Dasgupta",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, United States. Electronic address: adasgupta@kumc.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Predictors of cognitive dysfunction in hereditary transthyretin amyloidosis with liver transplant.",
"datePublished": "2022-10-17",
"url": "https://questionsmedicales.fr/article/36251860",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/13506129.2022.2131384"
}
},
{
"@type": "ScholarlyArticle",
"name": "Risk factors for cognitive dysfunction amongst patients with cardiovascular diseases.",
"datePublished": "2024-09-13",
"url": "https://questionsmedicales.fr/article/39346594",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2024.1385089"
}
},
{
"@type": "ScholarlyArticle",
"name": "Reward network dysfunction is associated with cognitive impairment after stroke.",
"datePublished": "2023-05-31",
"url": "https://questionsmedicales.fr/article/37307650",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.nicl.2023.103446"
}
},
{
"@type": "ScholarlyArticle",
"name": "Predictors of cognitive dysfunction one-year post COVID-19.",
"datePublished": "2023-01-05",
"url": "https://questionsmedicales.fr/article/36603126",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1037/neu0000876"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cognitive Dysfunction Biomarkers in Patients With Rheumatoid Arthritis: A Systematic Review.",
"datePublished": "2022-12-07",
"url": "https://questionsmedicales.fr/article/36729842",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/RHU.0000000000001888"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Coenzymes",
"item": "https://questionsmedicales.fr/mesh/D003067"
},
{
"@type": "ListItem",
"position": 4,
"name": "Biotine",
"item": "https://questionsmedicales.fr/mesh/D001710"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Biotine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Biotine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Biotine",
"description": "Comment diagnostiquer une carence en biotine ?\nQuels sont les signes cliniques d'une carence ?\nLes tests génétiques sont-ils utiles ?\nQuelle est la méthode de dépistage recommandée ?\nPeut-on diagnostiquer par des symptômes seuls ?",
"url": "https://questionsmedicales.fr/mesh/D001710?mesh_terms=Cognitive+Dysfunction&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Biotine",
"description": "Quels sont les symptômes d'une carence en biotine ?\nLa perte de cheveux est-elle un symptôme ?\nY a-t-il des symptômes digestifs ?\nLes troubles de l'humeur sont-ils liés ?\nLes éruptions cutanées sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D001710?mesh_terms=Cognitive+Dysfunction&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Biotine",
"description": "Comment prévenir une carence en biotine ?\nLes personnes à risque doivent-elles se supplémenter ?\nLes régimes restrictifs augmentent-ils le risque ?\nLes antibiotiques affectent-ils la biotine ?\nLes aliments transformés sont-ils un risque ?",
"url": "https://questionsmedicales.fr/mesh/D001710?mesh_terms=Cognitive+Dysfunction&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Biotine",
"description": "Comment traiter une carence en biotine ?\nQuels aliments sont riches en biotine ?\nLes suppléments sont-ils nécessaires ?\nY a-t-il des effets secondaires aux suppléments ?\nCombien de temps dure le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D001710?mesh_terms=Cognitive+Dysfunction&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Biotine",
"description": "Quelles complications peuvent survenir ?\nLa carence peut-elle affecter le développement ?\nY a-t-il des complications à long terme ?\nLes troubles mentaux sont-ils possibles ?\nLes complications cutanées sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D001710?mesh_terms=Cognitive+Dysfunction&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Biotine",
"description": "Qui est à risque de carence en biotine ?\nLes femmes enceintes sont-elles plus à risque ?\nLes personnes âgées sont-elles vulnérables ?\nLes végétariens sont-ils à risque ?\nLes personnes avec des troubles métaboliques sont-elles à risque ?",
"url": "https://questionsmedicales.fr/mesh/D001710?mesh_terms=Cognitive+Dysfunction&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une carence en biotine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par des tests sanguins mesurant les niveaux de biotine."
}
},
{
"@type": "Question",
"name": "Quels sont les signes cliniques d'une carence ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent fatigue, dépression, éruptions cutanées et perte de cheveux."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier des troubles métaboliques liés à la biotine."
}
},
{
"@type": "Question",
"name": "Quelle est la méthode de dépistage recommandée ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un dosage de la biotine dans le sérum est la méthode standard de dépistage."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer par des symptômes seuls ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes doivent être confirmés par des tests de laboratoire."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une carence en biotine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, dépression, éruptions cutanées et troubles neurologiques."
}
},
{
"@type": "Question",
"name": "La perte de cheveux est-elle un symptôme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la perte de cheveux est un symptôme courant d'une carence en biotine."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes digestifs ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme des nausées et des douleurs abdominales peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les troubles de l'humeur sont-ils liés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la dépression et l'irritabilité peuvent être des symptômes de carence."
}
},
{
"@type": "Question",
"name": "Les éruptions cutanées sont-elles fréquentes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des éruptions cutanées, souvent rouges et squameuses, sont fréquentes."
}
},
{
"@type": "Question",
"name": "Comment prévenir une carence en biotine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée incluant des aliments riches en biotine aide à prévenir la carence."
}
},
{
"@type": "Question",
"name": "Les personnes à risque doivent-elles se supplémenter ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes à risque, comme les femmes enceintes, devraient envisager des suppléments."
}
},
{
"@type": "Question",
"name": "Les régimes restrictifs augmentent-ils le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les régimes très restrictifs peuvent augmenter le risque de carence en biotine."
}
},
{
"@type": "Question",
"name": "Les antibiotiques affectent-ils la biotine ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains antibiotiques peuvent perturber l'absorption de la biotine."
}
},
{
"@type": "Question",
"name": "Les aliments transformés sont-ils un risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les aliments transformés peuvent être pauvres en biotine et augmenter le risque."
}
},
{
"@type": "Question",
"name": "Comment traiter une carence en biotine ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement consiste en des suppléments de biotine et des modifications alimentaires."
}
},
{
"@type": "Question",
"name": "Quels aliments sont riches en biotine ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les œufs, les noix, le soja et les légumes à feuilles vertes sont riches en biotine."
}
},
{
"@type": "Question",
"name": "Les suppléments sont-ils nécessaires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, dans les cas de carence, des suppléments peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux suppléments ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires sont rares, mais peuvent inclure des troubles gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "Combien de temps dure le traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut durer plusieurs semaines, selon la gravité de la carence."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles neurologiques et des problèmes cutanés graves."
}
},
{
"@type": "Question",
"name": "La carence peut-elle affecter le développement ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chez les enfants, une carence peut affecter le développement physique et mental."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications à long terme ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une carence prolongée peut entraîner des problèmes de santé chroniques."
}
},
{
"@type": "Question",
"name": "Les troubles mentaux sont-ils possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles mentaux comme la dépression peuvent être exacerbés par une carence."
}
},
{
"@type": "Question",
"name": "Les complications cutanées sont-elles fréquentes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications cutanées comme des infections peuvent survenir en cas de carence."
}
},
{
"@type": "Question",
"name": "Qui est à risque de carence en biotine ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes ayant une alimentation déséquilibrée ou des troubles digestifs sont à risque."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes enceintes ont des besoins accrus en biotine et peuvent être à risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles vulnérables ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent avoir des carences en raison d'une absorption réduite."
}
},
{
"@type": "Question",
"name": "Les végétariens sont-ils à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les végétariens peuvent être à risque s'ils ne consomment pas d'aliments riches en biotine."
}
},
{
"@type": "Question",
"name": "Les personnes avec des troubles métaboliques sont-elles à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains troubles métaboliques peuvent affecter l'absorption de la biotine."
}
}
]
}
]
}
Cognitive dysfunction is part of the broad spectrum of clinical manifestations in older untreated hereditary transthyretin amyloidosis patients with peripheral polyneuropathy....
The objective of this study is to systematically explore cognitive dysfunction in ATTRV30M amyloidosis patients whose disease course was modified by liver transplant (LT)....
A series of 269 carriers of TTRVal30Met mutation treated with LT underwent a neuropsychological assessment. Clinical charts were reviewed to identify focal neurological episodes (FNEs), cognitive comp...
Cognitive dysfunction was identified in 35 patients (13%)-14 (5%) had mild and 21 (8%) had moderate dysfunction. In comparison to normal cognition, both mild and moderate cognitive dysfunction patient...
Consistent with the natural history of the disease, older age and higher severity of the disease are significantly associated and potentially predictors of cognitive dysfunction in ATTRV30M patients t...
The impact of cardiovascular diseases on cognition raises important research questions. The study aimed to investigate the relationship between demographic data, cardiovascular diseases, kidney diseas...
A cross-sectional study of patients with cardiovascular diseases was performed. The Montreal Cognitive Assessment (MoCA) was applied for cognitive evaluation. Based on MoCA three groups were defined: ...
Of 628 patients, 55.2% had mild CD, and the mean age was 67.95 (SD 9.53) years. Cα and Mω were 0.7, indicating good internal consistency. We found a moderate positive correlation between depression an...
Mild CD was the most common in patients with cardiovascular diseases. Older age, lower education, being a non-smoker, and renal dysfunction were risk factors for both mild and advanced CD. Female gend...
Stroke survivors not only suffer from severe motor, speech and neurocognitive deficits, but in many cases also from a "lack of pleasure" and a reduced motivational level. Especially apathy and anhedon...
(a) To characterize the frequency of objective cognitive deficits and self-perceived cognitive difficulties and (b) to explore demographic and clinical predictors of cognitive dysfunction and cognitiv...
One hundred and ten adults diagnosed with COVID-19 between March and November 2020, aged ≤ 74 years underwent a brief neuropsychological evaluation 12 months after infection, which included: Brief Vis...
Twenty participants (18.2%) had cognitive dysfunction and 36 (33.3%) had cognitive complaints. Cognitive dysfunction was related to lower education, preinfection history of headache/migraine, and acut...
A subset of individuals develops cognitive difficulties in the context of post-COVID syndrome. Results may support the protective effect of education, a known proxy of cognitive reserve. COVID-19 infe...
During the last years, a growing number of studies have investigated the link between cognitive dysfunction and rheumatoid arthritis (RA), highlighting the potential pathogenic role of several clinica...
We performed a systematic review using PRISMA (Preferred Reported Items for Systematic Reviews and Meta-analysis) protocol. A systematic search was conducted in the PubMed/MEDLINE, EMBASE, LILACS, Sco...
Five original studies were included, which provided data from 428 participants. Among plasma proteins, SHH was increased and TTR was reduced in patients with mild cognitive impairment; anti-myelin bas...
Despite the relative scarcity of studies on this subject and the heterogeneity of results, we identified possible biomarkers for cognitive deficits in the RA population. Further longitudinal studies a...
Toll-like receptors (TLRs) are pattern recognition receptors (PRRs) with a well-documented role in the innate and adaptive immune responses. Interestingly, TLR activation has also been linked to sever...
The origin of pre-existing cognitive impairment in stroke patients remains controversial, with a vascular or a degenerative hypothesis....
To determine whether endothelial dysfunction is associated with pre-existing cognitive problems, lesion load and biological anomalies in stroke patients....
Patients originated from the prospective STROKDEM study. The baseline cognitive state, assessed using the IQ-CODE, and risk factors for stroke were recorded at inclusion. Patients with an IQ-CODE scor...
A total of 86 patients were included (52 males; mean age 63.5 ± 11.5 years). Patients with abnormal RHI have hypertension or antihypertensive treatment more often. The baseline IQ-CODE was abnormal in...
A vascular mechanism may be responsible for cognitive problems pre-existing stroke. The measurement of endothelial dysfunction after stroke could become an important element of follow-up, providing an...
There is increasing recognition of the prevalence and impact of cognitive dysfunction (CD) in heart failure (HF) patients. This contemporary review appraises the evidence for epidemiological associati...
CD disproportionately affects heart failure patients, even accounting for known comorbid risk factors, and this may extend to subclinical left ventricular dysfunction. Neuroimaging studies now provide...
Cognitive dysfunction is increasingly recognized as a complication and comorbidity of diabetes, supported by evidence of abnormal brain structure and function. Although few mechanistic metabolic studi...
There is limited data on cognition in patients undergoing peritoneal dialysis (PD). We assessed prevalence and associated risk factors of neurocognitive impairment (NCI) in PD patients....
A cross-sectional cohort study of 149 PD patients at a single centre between 2016 and 2020 who underwent neurocognitive screening at defined intervals by Addenbrooke's Cognitive Examination - Revised ...
Patients on PD performed poorly in ACE-R screening compared to population norms, with discrepancy in all cognitive domains. In patients without CVD, attention and language domains were comparable to n...
Patients on PD have higher prevalence of NCI than the general population, primarily with impairments in memory, fluency and visuospatial reasoning. CVD confers poorer performance in attention and lang...